US Patent 11219644 Universal immune cells for cancer immunotherapy
Patent 11219644 was granted and assigned to Baylor College of Medicine on January, 2022 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
January 26, 2016
Date of Patent
January 11, 2022
Patent Applicant
Patent Application Number
15546259
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11219644 Universal immune cells for cancer immunotherapy
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
